Ameena Westwood, 53, started getting 'bad cough and shortness of breath' before being told her breast cancer had 'spread to my spine, pelvis, ribs and sternum' ...
A report from Macmillan estimated a record 3.5m in the UK are living with cancer in 2025, including 98,000 in Northern ...
Approval is based on results from the TROPION-Breast01 Phase III trial, in which Datroway demonstrated a significant reduction in the risk of disease progression or death in patients with previously ...
The FDA has approved AstraZeneca and Daiichi Sankyo’s Datroway (datopotamab deruxtecan-dlnk) to treat unresectable or ...
Hosted on MSN5h
Heart Patients Are At An Increased Risk Of Advanced Breast Cancer- Here’s How To Protect YourselfHeart disease increases the likelihood of advanced breast cancer. Hormone receptor-positive tumors are linked to ...
The FDA's nod is based on late-stage data, which show AZN's Datroway cuts the risk of disease progression/death by 37% vs ...
The approval was based on results from the TROPION-Breast01 Phase III trial.
New Treatments for HR-Positive Breast Cancer and Mantle Cell Lymphoma Offer Promising Outcomes and Expanded Options for ...
AstraZeneca (AZ) and Daiichi Sankyo’s Datroway (datopotamab deruxtecan-dlnk) has been approved by the US Food and Drug ...
15h
Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery ...
Two recent studies from researchers at Washington University School of Medicine in St. Louis have identified a promising way ...
Tokyo: Daichi Sankyo has announced that DATROWAY (datopotamab deruxtecan-dlnk) has been approved in the U.S. for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback